ondansetron

Generic: ondansetron

Labeler: west-ward pharmaceuticals corp
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ondansetron
Generic Name ondansetron
Labeler west-ward pharmaceuticals corp
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

ondansetron hydrochloride 2 mg/mL

Manufacturer
West-Ward Pharmaceuticals Corp

Identifiers & Regulatory

Product NDC 0143-9890
Product ID 0143-9890_7dd1fe92-e406-4dde-a0e7-abfc496ccfc3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076781
Listing Expiration 2026-12-31
Marketing Start 2006-12-26

Pharmacologic Class

Classes
serotonin 3 receptor antagonists [moa] serotonin-3 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01439890
Hyphenated Format 0143-9890

Supplemental Identifiers

RxCUI
283504 1740467
UNII
NMH84OZK2B

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ondansetron (source: ndc)
Generic Name ondansetron (source: ndc)
Application Number ANDA076781 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01)
  • 10 VIAL, MULTI-DOSE in 1 CARTON (0143-9890-10) / 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01)
source: ndc

Packages (2)

Ingredients (1)

ondansetron hydrochloride (2 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "7dd1fe92-e406-4dde-a0e7-abfc496ccfc3", "openfda": {"unii": ["NMH84OZK2B"], "rxcui": ["283504", "1740467"], "spl_set_id": ["bb4bc810-db26-471b-9ce7-6e2fb3018af0"], "manufacturer_name": ["West-Ward Pharmaceuticals Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01)", "package_ndc": "0143-9890-01", "marketing_start_date": "20061226"}, {"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (0143-9890-10)  / 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01)", "package_ndc": "0143-9890-10", "marketing_start_date": "20061226"}], "brand_name": "Ondansetron", "product_id": "0143-9890_7dd1fe92-e406-4dde-a0e7-abfc496ccfc3", "dosage_form": "INJECTION", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "0143-9890", "generic_name": "Ondansetron", "labeler_name": "West-Ward Pharmaceuticals Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA076781", "marketing_category": "ANDA", "marketing_start_date": "20061226", "listing_expiration_date": "20261231"}